PHA Pharmagest Interactive SA

Equasens: acquisition of DIS and RESURGENCES BUSINESSES

Equasens: acquisition of DIS and RESURGENCES BUSINESSES

Villers-lès-Nancy (France), 30 June 2025 - 06:00 PM (CET)

PRESS RELEASE

EQUASENS ACQUIRES DIS AND RESURGENCES BUSINESSES, STRENGTHENING ITS POSITION IN THE MARKET OF SOFTWARE SOLUTIONS FOR HEALTHCARE ESTABLISHMENTS.

Strengthening the position of a leading provider of software solutions for hospitals and the medical-social sector

  • Transaction finalised: acquisition of Novaprove, publisher of ResUrgences software and the DIS business assets, (GESDIS, FACDIS, ARCADIS ranges)
  • Acquisition scope: more than 300 customers in the public healthcare sector, with annual revenue of around €5 million
  • The AXIGATE LINK Division strengthens its position in the market of software solutions for public healthcare establishments
  • Industrial synergies: The AXIGATE LINK Division expands its range of digital products and services for health and medico-social establishments.

***

(Euronext Paris™ - Compartment B - FR 0012882389 -$EQS), announces the completion of the acquisition on July 1, 2025, by its AXIGATE LINK Division through its subsidiary Axigate, of two businesses specialising in solutions for the public healthcare sector from a French software solutions editor.

This strategic acquisition which is a product of the exclusive negotiations announced on 30 April will contribute to Equasens' goal to significantly strengthen its position in the hospital and medico-social software market, by creating a complete technology ecosystem to support the digital transformation of public and private establishments.

Scope and impact of the acquisition

The acquired business assets cover more than 300 customers in the public healthcare sector and generate annual sales of around €5m. They include:

  • ResUrgences (Novaprove): a cloud-based software platform specialising in the management of hospital emergency services, equipping 8 university hospitals (CHU) and a total of 75 customers. This functionally reliable and robust technological solution optimises the management of emergency department patient flows and care delivery processes.



  • DIS range: digital solutions for public healthcare establishments. 215 sites are equipped with the DIS range, including 125 healthcare establishments (hospitals) and 90 medico-social establishments (mainly nursing homes). This range integrates the management of EPR (Electronic Patient Records), billing, accounting, business and financial management and HR management, including payroll management solutions. The suite also includes inventory and purchasing management, providing solutions for in-house pharmacies.



These two activities have been integrated into the AXIGATE LINK Division, and will strengthen the HOSPILINK solution for Hospitals, Regional Hospital Groups (GHT) and specialised after-care and rehabilitation facilities and psychiatric facilities in France.

Growth strategy in action

This acquisition is fully in line with Equasens' strategy for:

  • developing software solutions for public health establishments, a market with numerous renewal and equipment opportunities,
  • and strengthening the Group's offering for both the private practice and hospital segments over the entire patient care pathway.

The resulting technical and commercial synergies with the AXIGATE LINK Division's existing solutions will be a major growth driver by optimising resources and accelerating innovation.

This acquisition significantly reinforces the Group's position as a key force in the transformation of the digital healthcare ecosystem, providing an even more precise and comprehensive solution for management and EPR (Electronic Patient Records) needs of healthcare establishments and their practitioners.

An industrial growth model and future prospects

The integration of these activities within the AXIGATE LINK Division reflects a clear industrial vision: to expand and complete its software offering for healthcare establishments by adding new technology building blocks to the AXIGATE LINK Division's EPR solutions in various areas (accounting, billing, stock management and payroll).

The short-term objective is to develop the new building blocks originating from the acquisition to be integrated into the existing AXIGATE LINK Division ranges: HOSPILINK (hospital), TITANLINK (nursing homes) and DOMILINK (home care). For ResUrgences, the aim is to strengthen this specialized range while integrating it into the HOSPILINK range as a full-fledged module.

The medium-term objective is to create smooth, secure patient care pathways, by improving interoperability between the various services and users, based on our different solutions for institutions (emergency services, nursing homes, hospitals, hospital-at-home programmes, in-home nursing care services) and private healthcare practitioners (physicians, allied health professionals, pharmacies), by developing new functionalities based on artificial intelligence and data analysis, making it possible to retrieve information from patient records throughout the patient's care pathway.

Denis Supplisson, Chief Executive Officer of Equasens, commented: "This acquisition illustrates our determination to expand and diversify within our core business - software for both private practice and hospital healthcare professionals - by targeting opportunities that make industrial and economic sense. By integrating the ResUrgences and DIS ranges, we are combining the added value of our medico-social and healthcare offerings to meet the growing digital needs of healthcare establishments. Our goal is to become the technology partner of choice to support the transformation of the French healthcare system, by harnessing the potential of innovation to benefit people: improving the handling of administrative and medical tasks to save time for users.

Grégoire de Rotalier, Deputy CEO of Equasens and Manager of the AXIGATE LINK Division, added: "For Equasens and the AXIGATE LINK Division, this quality acquisition significantly strengthens our presence in the public health sector, in terms of market share, expertise and product range. This acquisition further reinforces AXIGATE LINK's strong position in the hospital, medico-social and home care sectors, and strengthens a team of 270 employees fully focused on serving 5,000 healthcare and medico-social establishment customers. ”

Timetable and integration

Operational integration of the teams and solutions will begin in Q3 2025, with a phased migration plan for customers to Equasens' new technology platforms. Continuity of service is guaranteed throughout the transition period.

Upcoming financial communications

  • 31 July 2025: Q2 2025 revenue - After the close of trading
  • 26 September 2025: H1 2025 results: 26 September 2025

About - Follow us also on

Founded over 35 years ago, Equasens Group, a leader in digital healthcare solutions, today employs over 1.400 people across Europe.

Equasens Group’s specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as data hosting, financing and training adapted to their specific needs.

And reflecting the spirit of its tagline "Technology for a More Human Experience", the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient and secure healthcare system.

Listed on Euronext Paris, Equasens Group (Compartment B - FR 0012882389 – $EQS) applies a two-pronged development strategy combining organic growth with targeted acquisitions at a European level.

CONTACTS

Analyst and Investor Relations:

Chief Administrative and Financial Officer: Frédérique Schmidt

Tel: +33 (0)3 83 15 90 67 -

Financial communications agency:

FIN’EXTENSO - Isabelle Aprile

Tel.: +33 (0)6 17 38 61 78 –

Forward-looking statements

This press release contains forward-looking statements that are not guarantees of future performance and are based on current opinions, forecasts and assumptions, including, but not limited to, assumptions about Equasens' current and future strategy and the environment in which Equasens operates. These involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements, or industry results or other events, to materially differ from those expressed in or implied by such forward-looking statements. These risks and uncertainties include those detailed in Chapter 3 "Risk factors" of the Universal Registration Document filed with the French financial market authority (Autorité des Marchés Financiers or AMF) on April 29, 2025 under number D.25-0334. These forward-looking statements are valid only as of the date of this press release.

Attachment



EN
30/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pharmagest Interactive SA

 PRESS RELEASE

EQUASENS : Mise à disposition du rapport financier semestriel 2025

EQUASENS : Mise à disposition du rapport financier semestriel 2025 Villers-lès-Nancy, le 30 septembre 2025 - 18h00 (CET) COMMUNIQUE DE PRESSE EQUASENS annonce la publication de son rapport financier semestriel au 30 juin 2025 EQUASENS annonce que son rapport financier semestriel 2025 a été déposé auprès de l’Autorité des Marchés Financiers (AMF) en date du 30 septembre 2025. Ce document est disponible sur le site Internet de l’AMF ainsi que sur celui d’EQUASENS : (Rubrique INVESTISSEURS / Section INFORMATION RÉGLEMENTÉE). Ce rapport financier semestriel est composé de la déclaration...

 PRESS RELEASE

EQUASENS : Bilan S1 2025 contrat de liquidité

EQUASENS : Bilan S1 2025 contrat de liquidité Villers-lès-Nancy, le 29 septembre 2025 - 08h00 (CET) COMMUNIQUE DE PRESSE BILAN SEMESTRIEL S1-2025 DU CONTRAT DE LIQUIDITECONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT Au titre du contrat de liquidité confié par la société EQUASENS à la Société de Bourse Gilbert Dupont, à la date du 30 juin 2025, les moyens suivants figuraient au compte de liquidité : Nombre d’actions : 3 540Solde en espèces : 55 775,07 €. Au cours du 1er semestre 2025, il a été négocié un total de : ACHAT59 121 titres2 428 700,43 €2 337 transactionsVENTE58 884 titr...

Arnaud Riverain
  • Arnaud Riverain

EQUASENS (EQS) - Résultats S1 : Les investissements se poursuivent / A...

CA S1 116 M€ +7,4% ROC 21,1 M€ +1,2% / Marge opérationnelle courante 18,2% vs 19,3% au S1 2024 RN 18,1 M€ stable / Marge nette 15,6% vs 16,7% Dette financière nette -98,8 M€ / Gearing -41,3% vs -33,1% au 31/12/24 CA S2 attendu en progression de près de +10%

 PRESS RELEASE

Equasens: 2025 half-year results

Equasens: 2025 half-year results Villers-lès-Nancy, 26 September 2025 - 6:00 PM (CET) PRESS RELEASE 2025 half-year results Revenue: €116.0m (+7.4% reported and +6.4% like-for-like)Recurring EBITDA: €29.8m (+5.5%)Current Operating Profit €21.1m (+1.2%) Net Profit: €18.1m (+0.3%)Net Financial Surplus : €98.8m (+€19.2m / 31-12-2024) H1 2025 RESULTS(M€)2024Reported basis2025Reported basisChange / Reported basisRevenue108.0116.08.07.4%Recurring EBITDA28.229.81.55.5%Recurring EBITDA / Sales26.1%25.7%  Current operating profit20.921.10.21.2%COP / Sales19.3%18.2%  Net Profit18.118.10.00.3%Net ...

 PRESS RELEASE

EQUASENS : Résultats semestriels 2025

EQUASENS : Résultats semestriels 2025 Villers-lès-Nancy, le 26 septembre 2025 - 18h00 (CET) COMMUNIQUE DE PRESSE Résultats semestriels 2025 Chiffre d'affaires : 116,0 M€ (+7,4% en publié et +6,4% en organique)EBITDA courant : 29,8 M€ (+5,5%)Résultat Opérationnel Courant : 21,1 M€ (+1,2%) Résultat Net : 18,1 M€ (+0,3%)Excédent financier net : 98,8 M€ (+19,2 M€ / 31-12-2024) RESULTATS S1 2025 (M€)Publié 2024Publié 2025Variation/publiéChiffre d'affaires108,0116,08,07,4%EBITDA courant28,229,81,55,5%EBITDA courant / CA26,1%25,7%  ROC20,921,10,21,2%ROC / CA19,3%18,2%  Résultat Net18,118,10,0...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch